Anti-Inflammatory Effects of Hyperoside in Human Endothelial Cells and in Mice
- 6 August 2014
- journal article
- Published by Springer Nature in Inflammation
- Vol. 38 (2) , 784-799
Abstract
High-mobility group box 1 (HMGB1) was recently shown to be an important extracellular mediator of systemic inflammation, and endothelial cell protein C receptor (EPCR) has been shown to be involved in vascular inflammation. Hyperoside is an active compound isolated from Rhododendron brachycarpum G. Don (Ericaceae) that was reported to have anti-oxidant, anti-hyperglycemic, anti-cancer, and anti-coagulant activities. Here, we show, for the first time, the anti-septic effects of hyperoside in HMGB1-mediated inflammatory responses and on the shedding of EPCR in vitro and in vivo. The data showed that hyperoside posttreatment suppressed lipopolysaccharide (LPS)-mediated release of HMGB1 and HMGB1-mediated cytoskeletal rearrangement. Hyperoside also inhibited HMGB1-mediated hyperpermeability and leukocyte migration in septic mice and phorbol-12-myristate 13-acetate (PMA) of cecal ligation and puncture (CLP)-induced EPCR shedding. In addition, hyperoside inhibited the production of tumor necrosis factor-α (TNF-α) and the HMGB1-mediated activation of Akt, nuclear factor-κB (NF-κB), and extracellular regulated kinase (ERK) 1/2 in HUVECs. Hyperoside also reduced the CLP-induced release of HMGB1, the production of interleukin (IL)-1β, and septic mortality. Collectively, these results suggest hyperoside as a candidate therapeutic agent for the treatment of vascular inflammatory diseases via inhibition of the HMGB1 signaling pathway.Keywords
This publication has 63 references indexed in Scilit:
- Phenolic content of Ruprechtia salicifolia leaf and its immunomodulatory, anti-inflammatory, anticancer and antibacterial activityJournal of Pharmacy Research, 2013
- High Mobility Group Box-1 Promotes the Proliferation and Migration of Hepatic Stellate Cells via TLR4-Dependent Signal Pathways of PI3K/Akt and JNKPLOS ONE, 2013
- Inhibitory effects of epi-sesamin on HMGB1-induced vascular barrier disruptive responses in vitro and in vivoToxicology and Applied Pharmacology, 2013
- Polyphosphate elicits pro‐inflammatory responses that are counteracted by activated protein C in both cellular and animal modelsJournal of Thrombosis and Haemostasis, 2012
- Activated protein C inhibits high mobility group box 1 signaling in endothelial cellsBlood, 2011
- HMGB1 induces human lung endothelial cell cytoskeletal rearrangement and barrier disruptionMicrovascular Research, 2011
- Mitogen-Activated Protein Kinase Signaling in the Heart: Angels Versus Demons in a Heart-Breaking TalePhysiological Reviews, 2010
- Regulation of endothelial protein C receptor shedding by cytokines is mediated through differential activation of MAP kinase signaling pathwaysExperimental Cell Research, 2009
- The ligand occupancy of endothelial protein C receptor switches the protease-activated receptor 1-dependent signaling specificity of thrombin from a permeability-enhancing to a barrier-protective response in endothelial cellsBlood, 2007
- Luteolin, a flavonoid, inhibits AP-1 activation by basophilsBiochemical and Biophysical Research Communications, 2006